(Clostridioides difficile) is bacteria that causes about 500,000 infections a year in the United States, according to the U.S ...

Clostridium difficile infection (CDI ... Although metronidazole and vancomycin are and have been the mainstay treatment options for CDI, there are some unmet medical and therapeutical needs.

T he antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C.

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

It can also increase the chance of your UC therapy becoming ineffective, so you may need to change or intensify your treatment plan. People with UC and C. diff infections can also be more likely ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

Once C-diff is in the ascendancy it can be very hard to shift – the traditional treatment is antibiotics but a significant number of patients do not respond and are left with relentless and ...